Evaluation of immunoglobulin production during tularaemia infection in BALB/c mouse model

Acta Veterinaria Brno

Volumn 76, Issue 4, 2007, Pages 579-584

  Pohanka, Miroslav ^a,b  

^a Centre of Biological Defense   (Czech Republic)

^b CBO Centre of Biological Defence   (Czech Republic)

Author keywords

Chromatography; Francisella tularensis; Immunoglobulin; Protein G; Protein L

Indexed keywords

FRANCISELLA TULARENSIS; MUS;

EID: 42449132889     PISSN: 00017213     EISSN: None     Source Type: Journal    
DOI: 10.2754/avb200776040579     Document Type: Article

References (18)

1. AKERTRÖM B, BJÖRCK L 1989: Protein L-an immunoglobulin light chain-binding bacterial protein. Characterization of binding and physicochemical properties. J Biol Chem 264: 19740-19746
2. BJÖRCK L, KRONVALL G 1984: Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 133: 969-974
3. COLE LE, ELKINS KL, MICHALEK SM, QURESHI N, EATON LJ, RALLABHANDI P, CUESTA N, VOGEL SN 2006: Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J Immunol 176: 6888-6899
4. CULKIN SJ, RHINEHART-JONES T, ELKINS KL 1997: A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol 158: 3277-3284
5. DENIS DT, IGLESB Y TV, HENDERSON DA, BARTLET JG, ASCHER MS, EIT ZEN E, FINE AD, FRIEDLANDER AM, HAUER J, LAYTON M, LILIBRIDGE SR, MCDADE JE, OSTERHOLM MT, O'TOOLE T, PARKER G, PERL TM, RUSEL PK, TONAT K 2001: Tularaemia as a biological weapon - medical and public health management. J Am Med Assoc 285: 2763-2773
6. DREISBACH VC, COWLEY S, ELKINS KL 2000: Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon. Infect Immun 68: 1988-1996
7. ELKINS KL, COWLEY SC, BOSIO CM 2003: Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect 5: 135-142
8. ELKINS KL, LEIBY DA, WINEGAR RK, NACY CA, FORTIER AH 1992: Rapid generation of specific protective immunity to Francisella tularensis. Infect Immun 60: 4571-4577
9. ERICSSON M, SANDSTROM G, SJOSTEDT A, TARNVIK A 1994: Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J Infect Dis 170: 110-114
10. FORTIER AH, SLA YTER MV, ZIEMBA R, MELT ZER MS, NACY CA 1991: Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect Immun 59: 2922-2928
11. GREEN M, CHOULES G, ROGERS D, TITBALL RW 2005: Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Vaccine 23: 2680-2686
12. HUBÁLEK Z, SIXL W, HALOUZKA J 1998: Francisella tularensis in Dermacentor reticulatus ticks from the Czech Republic and Austria. Wien Klin Wochenschr 110: 909-910
13. HUBÁLEK Z, TREML F, JUŘICOVÁ Z, HUŇADY M, HALOUZKA J, JANÍK V, BILL D 2002: Serological survey of the wild boar (Sus scrofa) for tularaemia and brucellosis in South Moravia, Czech Republic. Vet Med-Czech 47:60-66
14. KOSKELA P, SALMINEN A 1985: Humoral immunity against Francisella tularensis after natural infection. J Clin Microbiol 22: 973-979
15. LOPEZ MC, DUCKETT NS, BARON SD, METZGER DW 2004: Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS. Cell Immunol 232: 75-85
16. PIKULA J, BEKLOVÁ M, HOLEŠOVSKÁ Z, TREML F 2004: Ecology of European brown hare and distribution of natural foci of tularaemia in the Czech Republic. Acta Vet Brno 73: 267-273
17. POHANKA M, PAVLIŠ O, SKLÁDAL P 2007: Diagnosis of tularaemia using piezoelectric biosensor technology. Talanta 71: 981-985
18. PULEN RL, STUART BM: 1945: Tularaemia: analysis of 225 cases. J Am Med Assoc 129: 495-500